Literature DB >> 4571425

The primary and secondary antibody response to Escherichia coli O6 lipopolysaccharide analysed at the humoral and cellular level. Amount and avidity of the antibodies in relation to protective capacity.

S Ahlstedt, J Holmgren, L A Hanson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4571425      PMCID： PMC1423004     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  26 in total

1.  VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE.

Authors:  H N EISEN; G W SISKIND
Journal:  Biochemistry       Date:  1964-07       Impact factor: 3.162

2.  The development of the phage-inactivating properties of serum during the course of specific immunization of an animal: reversible and irreversible inactivation.

Authors:  N K JERNE; P AVEGNO
Journal:  J Immunol       Date:  1956-03       Impact factor: 5.422

3.  Significance of amount and avidity of E. coli O antibodies for manifestation of their serological and protective properties. A preliminary study.

Authors:  S Ahlstedt; J Holmgren; L A Hanson
Journal:  Int Arch Allergy Appl Immunol       Date:  1972

4.  Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. 3. Studies on the average avidity of the antibody produced by specific plaque-forming cells.

Authors:  P J Baker; B Prescott; P W Stashak; D F Amsbaugh
Journal:  J Immunol       Date:  1971-09       Impact factor: 5.422

5.  Immunodiffusion studies on Escherichia coli. 2. Characterization of antigens used for passive haemagglutination with an O 6 strain as model.

Authors:  J Holmgren; L A Hanson
Journal:  Acta Pathol Microbiol Scand       Date:  1969

6.  The asynchronous development of immunological memory in helper (T) and precursor (B) cell lines.

Authors:  A J Cunningham; E E Sercarz
Journal:  Eur J Immunol       Date:  1971-12       Impact factor: 5.532

7.  Induction of "low dose" tolerance to a bacterial somatic antigen in neonatal mice.

Authors:  J L Allen; H Friedman
Journal:  Nat New Biol       Date:  1971-09-15

8.  Characterization of precipitating antibodies to E. coli O antigen in infants and children with acute pyelonephritis.

Authors:  L A Hanson; J Holmgren; U Jodal; B Kaijser
Journal:  Clin Exp Immunol       Date:  1971-04       Impact factor: 4.330

9.  Studies on the regulation of avidity at the level of the single antibody-forming cell. The effect of antigen dose and time after immunization.

Authors:  B Andersson
Journal:  J Exp Med       Date:  1970-07-01       Impact factor: 14.307

10.  THE ISOLATION AND BIOLOGICAL ACTIVITIES OF RABBIT GAMMA M- AND GAMMA G-ANTI-SALMONELLA TYPHIMURIUM ANTIBODIES.

Authors:  J B ROBBINS; K KENNY; E SUTER
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307
View more
  11 in total

1.  Antibody response to Escherichia coli O antigens and influence of the protein moiety of the endotoxin.

Authors:  S Ahlstedt; L Lindholm
Journal:  Immunology       Date:  1977-11       Impact factor: 7.397

2.  The validity of the ammonium sulphate precipitation technique of estimation of antibody amount and avidity.

Authors:  S Ahlstedt; J Holmgren; L A Hanson
Journal:  Immunology       Date:  1973-12       Impact factor: 7.397

3.  Experimental Escherichia coli O6 pyelonephritis in rabbits. Effect on O6 antibody quantity and avidity of prior immunization with E. coli O2 bacteria.

Authors:  S Ahlstedt; B Kaijser
Journal:  Immunology       Date:  1975-05       Impact factor: 7.397

4.  Antibody-dependent cell-mediated cytotoxicity against Escherichia coli O antigens.

Authors:  M Hagberg; S Ahlstedt; L Hanson
Journal:  Eur J Clin Microbiol       Date:  1982-02       Impact factor: 3.267

5.  Local antibody production in experimental pyelonephritis: amount, avidity, and immunoglobulin class.

Authors:  J Smith; J Holmgren; S Ahlstedt; L A Hanson
Journal:  Infect Immun       Date:  1974-09       Impact factor: 3.441

6.  A minimal physiologically based pharmacokinetic model that predicts anti-PEG IgG-mediated clearance of PEGylated drugs in human and mouse.

Authors:  M D McSweeney; T Wessler; L S L Price; E C Ciociola; L B Herity; J A Piscitelli; W C Zamboni; M G Forest; Y Cao; S K Lai
Journal:  J Control Release       Date:  2018-06-05       Impact factor: 9.776

7.  Alteration of the antibody response to Escherichia coli O antigen in mice by prior exposure to various somatic antigens.

Authors:  S Ahlstedt; J Holmgren
Journal:  Immunology       Date:  1975-09       Impact factor: 7.397

8.  Antigen presentation as a factor in the protective immune response to renal infection.

Authors:  T E Miller; S Burnham
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

9.  Humoral immune response of rabbits to acholeplasmal lipoglycans.

Authors:  R J Lynn; P A Guidici; E J Hollemweguer; P F Smith
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441

10.  Enhancement of the IgG antibody production to Escherichia coli O antigen by prior exposure to serologically different E. coli bacteria.

Authors:  J Holmgren; S Ahlstedt
Journal:  Immunology       Date:  1974-01       Impact factor: 7.397
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.